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LIA versus regional blocks were compared for their analgesia requirements 
in recovery, calculated as morphine equivalents� Patient controlled analgesia 
(PCA) use and length of stay (LOS) were also studied� Data was analysed 
using SPSS 22� Results: We collected 4020 data points� Forty-eight (23�9%) 
patients had regional blocks, 110 (54�7%) patients had LIA, 8 (4%) patients 
received both regional block and LIA and 35 (17�4%) patients received neither� 
Of the patients who had regional blocks, 70�8% (n=34) required parenteral 
analgesia in recovery compared to 42�7% (n=47) who had intraoperative 
LIA� The median opioid requirements (morphine equivalents) in PACU were 
6�8 mg (regional, range 0-27) and 0 mg (LIA, 0-30) (p=0�061)� Conclusion: 
LIA may provide superior analgesic effect compared to regional blocks in 
patients in the early post-operative period. This is a significant finding as 
effective analgesia is essential for early rehabilitation, associated with shorter 
LOS and better functional outcomes� Future randomised controlled trials 
investigating LIA are warranted� 
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Background/Aims: Neuroendocrine abnormalities are frequently 
observed in patients with schizophrenia and are believed to interact 
with pathophysiological mechanisms of psychosis� Cortisol awakening 
response (CAR), the increase in cortisol secretion in response to waking 
up, is a standardised cortisol readout that shows strong associations with 
social and environmental risk factors of schizophrenia and with adverse 
physical health outcomes� Over the last few years an increasing number of 
studies has reported flattening of the CAR in patients at different stages of 
psychosis but this data has not been synthesised� Methods: We performed 
a systematic review and meta-analysis of studies reporting CAR in patients 
with schizophrenia, first episode psychosis or at risk states. A systematic 
search was performed using MEDLINE, PsychINFO and Embase and hand 
search of relevant reference lists�  We include studies that either directly 
report CAR, or report awakening and 30 minute post-awakening cortisol 
levels that allow for calculation of AUCi� Results: Patients with schizophrenia 
show an attenuated CAR compared to healthy controls� Subset meta-analysis 
showed that CAR alterations are already present in patients with first episode 
psychosis and individuals in at-risk states� Conclusion:  Despite the limited 
number of studies currently available, there is a clear trend for attenuated 
CAR in patients at different stages of psychosis� These distinctive alterations 
of the hypothalamic-pituitary-adrenal axis function appear to be already 
present in at-risk states� Few studies so far employed longitudinal designs 
and investigated the predictive value of CAR for transition from at risk states 
to first episode and for treatment response. 
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Background/Aims: Pancreatic cancer is the fourth most common cause of 
cancer-associated death worldwide, with a five-year survival rate less than 
5%� The poor prognosis is mainly due to late presentation in 80% of patients 
and its drug resistant nature� Most diagnoses are made using contrast-
enhanced computed tomography (CT) or magnetic resonance imaging 
(MRI), which have a limited sensitivity of 76-86%� Iron oxide nanoparticles 
are increasingly used in the diagnostic imaging of pancreatic cancer, due 
their ability to selectively target tumour cells thereby increasing image 
resolution�  The aim of this study is to identify studies investigating the use 
of iron oxide nanoparticles in the diagnostic imaging of pancreatic cancer� 
Methods: A systematic review was performed using PubMed for records up 
to 2015� Search terms used included ‘iron oxide nanoparticles’, ‘pancreatic 
cancer’ and ‘imaging’� Results: Sixteen studies were identified evaluating the 
use of iron oxide nanoparticles in the imaging of pancreatic cancer in vitro 
and in in-vivo animal models� Eight of these studies evaluated the use of 
superparamagnetic iron oxide nanoparticles (SPION), and showed SPION 
significantly decrease the T2 and T2* relaxation times of tumour tissue, 
providing a high sensitivity for MRI� Similar results were seen in eight studies 
that investigated the use of iron oxide nanoparticles conjugated to other 
molecules including gelatin, survivin, chemokine-receptor-4, silica-gold, 
endothelial growth factor receptor, urokinase receptor activator, Clostridium 
and a sonic-hedgehog target� Conclusion:  Iron oxide nanoparticles in the 
form of SPION or conjugates are biocompatible and effective at targeting 
tumour cells and significantly attenuate MRI signals in T2-weighted images 
of pancreatic cancers from a range of cell lines�
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Background/Aims: Proton pump inhibitors (PPIs) are commonly prescribed 
in the clinical setting� Current evidence shows an association between PPI use 
and fractures, pneumonia and enteric infections, with inconclusive findings 
on PPI use leading to vitamin B12 deficiency. This is particularly relevant in 
older adults as the physiological changes that occur with ageing predispose 
to illness and additional co-morbidities places older adults at greater risk of 
vitamin B12 deficiency. The aim of this study is to determine whether long term 
use of PPIs in the older adult population is related to vitamin B12 deficiency. 
Methods: A systematic review was conducted using PubMed, Embase and 
the Cochrane library from 1988 - 2015� Search terms used included: ‘proton 
pump inhibitors’,  ‘vitamin B12 deficiency’, ‘cobalamin’, ‘clinical studies’, 
‘elderly’ and ‘older adults’� Results: A total of seven studies were analysed, 
including one non-randomised controlled trial, one retrospective cohort 
study, two retrospective case-control studies, one cross-sectional study 
and two case reports� Four studies found an association between long term 
PPI use and vitamin B12 deficiency and a retrospective case-control study 
showed no association� Both case reports showed an association between 
long term PPI use and vitamin B12 deficiency. One case report demonstrated 
clinical manifestations of vitamin B12 deficiency. Conclusion:  Small scale 
clinical studies suggest that vitamin B12 absorption is impaired in individuals 
on PPI therapy.  This finding is supported by observational studies showing 
a reduction in vitamin B12 levels associated with long-term PPI therapy in 
participants over 60 years. It is not known if this association has a significant 
clinical impact� 
